Page 5 - Ladyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ladyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ladyn Today - Breaking & Trending Today

Dyne Therapeutics (NYSE:DYN) Upgraded by StockNews.com to "Sell"

StockNews.com upgraded shares of Dyne Therapeutics (NYSE:DYN – Free Report) to a sell rating in a report published on Friday morning. Several other research analysts have also commented on DYN. Chardan Capital reiterated a buy rating and set a $20.00 price objective on shares of Dyne Therapeutics in a research note on Friday, August 4th. […] ....

United States , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , Metlife Investment Management , Dyne Therapeutics Company Profile , Jpmorgan Chase Co , Dyne Therapeutics Inc , Swiss National Bank , Dyne Therapeutics , Free Report , Moderate Buy , Get Free Report , Gatti High , National Bank , Life Investment Management , Fund Advisors , Schwab Investment Management , Dyne Therapeutics Daily , Nyse Dyn , Stocknews Com ,

Dyne Therapeutics (NYSE:DYN) Releases Quarterly Earnings Results

Dyne Therapeutics (NYSE:DYN – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.99) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.16), MarketWatch Earnings reports. Dyne Therapeutics Price Performance Shares of NYSE DYN opened at $7.05 on Wednesday. The stock’s 50-day simple moving average is […] ....

United States , Dyne Therapeutics Inc , Securities Exchange Commission , Jpmorgan Chase Co , Blackrock Inc , Goldman Sachs Group Inc , Dyne Therapeutics , Get Free Report , Marketwatch Earnings , Chardan Capital , Gatti High , Exchange Commission , Street Corp , Sachs Group , Wasatch Advisors , Dyne Therapeutics Daily , Nyse Dyn ,